• NAGA SWAROOPA S Department of Pharmaceutical Regulatory Affairs, Shri Vishnu College of Pharmacy, Kovvada, Andhra Pradesh, India.
  • VENKATESWARA RAJU K Department of Pharmaceutical Regulatory Affairs, Shri Vishnu College of Pharmacy, Kovvada, Andhra Pradesh, India. https://orcid.org/0000-0001-8210-832X
  • PRASANTHI NL Department of Pharmaceutical Regulatory Affairs, Shri Vishnu College of Pharmacy, Kovvada, Andhra Pradesh, India.




MDR, MDD, Pre-market notification, NB, CE marking


The usage of medical device is on the rise due to the rise in incidence rate of chronic diseases, irregular health check-ups, and sedentary lifestyles and also rising cases of obesity, diabetes, neuro-based disorders, heart diseases, and chronic diseases relating to lifestyle disorders. Availability of hassle free home monitoring medical devices that can be used even by patients with no knowledge about the technical aspects made their way into patient homes. Even in the presence of restraining factors such as high cost and reimbursement issues, the opportunities for medical device professionals lie in the technological advancements and usage of internet of medical things in modern healthcare and the latest trend toward developing smart medical devices with fast development in (AI) and (ML). The usage of medical devices is on the rise due to medical device development is undergoing a huge technological advancement due to emergence 3D printing which allows development of devices designed specifically as per patient requirements. Medical devices like freestyle liber system by Abbott laboratories eliminate need for routine finger pricking as it has sensor that measures and records glucose levels through clothing of the consumer. Quickie Q300 M mini Wheelchair fits even in tight doorways, navigates restaurants, that are crowded and also in difficult living spaces. Harmonization of medical devices registration across the markets is essential to paue way for their easy approval and also in dealing with the withdrawn issues related to quality, safety, and performance. This review involves a comparative study of medical device regulations in four regions (US, EU, India and China).


Download data is not yet available.


Ganesh GN, Nishanthini B, Vidhya LT. Medical device regulation in, US, Europe, China and INDIA. Int J Drug Regul Aff 2017;5:17-25.

The European Parliament, the Council of the European Union. Directive 2007/47/EC of the European parliament and of 5 September 2007. Off J Eur Union 2007;75:35.

Majety RP, Katru S, Veluchuri JP, Juturi RK. New era in medical device regulations in the European Union. Pharm Reg Aff 2021;10:234.

Migliore A. On the new regulation of medical devices in Europe. Expert Rev Med Devices 2017;14:921-3. doi: 10.1080/17434440.2017.1407648, PMID 29157016

Emergo. India CDSCO Medical Device Registration and Approval; 2017. Available from: https://www.emergogroup.com/services/india/ indiamedical-device-registration [Last accessed on 2017 Feb 07].

Morulaa. Regulatory Approval and Classification Changes in 2017. CDSCO Medical Device Regulations in India. Available from: https:// morulaa.com; Available from: https://www.thehindu.com/opinion/op-ed/an-indecent-settlement/article28138182

Van Norman GA. Drugs, devices, and the FDA: Part 2: An overview of approval processes: FDA approval of medical devices. JACC Basic Transl Sci 2016;1:277-87.

Fargen KM, Frei D, Fiorella D, McDougall CG, Myers PM, Hirsch JA, et al. The FDA approval process for medical devices; an inherently flawed system, or valuable pathway for innovation? J Neurointerv Surg 2013;5:269-75. doi: 10.1136/neurintsurg-2012-010400, PMID 22764203

US Food and Drug Administration. Premarket Approval (PMA). Available from: https://www.fda.gov/medicaldevices/ deviceregulat ionandguidance/howtomarketyourdevice/ premarketsubmissions/premarketapprovalpma/default.htm [Last accessed on 2016 Mar 04].

Darrow JJ, Avorn J, Kesselheim AS. FDA regulation and approval of medical devices: 1976-2020. JAMA 2021;326:420-32. doi: 10.1001/ jama.2021.11171, PMID 34342614

Monsein LH. Primer on medical device regulation. Part I. History and background. Radiology 1997;205:1-9. doi: 10.1148/ radiology.205.1.9314952, PMID 9314952

Available from: https://www.einfochips.com/blog/an-overview-of-fda-regulations-for-medical-devices [Last accessed on 2022 Nov 17].

Available from: http://www.fda.gov/medicaldevices/device [Last accessed on 2016 Mar 04].

US Food and Drug Administration. CFR-code of Federal Regulations Title 21. Available from: https://www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=814& show FR=1&subpartNode=21: [Last accessed on 2016 Mar 04].

US Food and Drug Administration. Evaluation of Automatic Class III Designation (de novo) Summaries. About FDA/Centres offices/Office of Medical Products and Tobacco/CDRH/CDRH Transparency/ ucm232269.htm. Available from: https://www.fda.gov [Last accessed on 2016 Mar 04].

Food and Drug Administration. Investigational Device Exemptions, Code of Federal Regulation 21 CFR 812, Revised. United States: Food and Drug Administration; 2020.

US FDA Registration Process for Medical Devices and IVDs; 2015. Available from: https://www.emergobyul.com/resources/usa-process-chart [Last accessed on 2022 Nov 17].

Available from: https://www.fda.gov/medical-devices/recently-approved-devices/2022-device-approvals

Press Corner. European Commission-European Commission; 2017. New EU Rules to Ensure Safety of Medical Devices. Available from: https://www.ec.europa.eu

Briefing EU. Legislation in Progress-Medical Devices and in Vitro Diagnostic Medical Devices. 2017. Available from: https://www. europarl.europa.eu

El Azzouzi M. EU MDR 2017/745 Transition Timeline [Medical Device Regulation]. Medical Device Regulation and ISO Quality Standard. Monir el Azzouzi; 2018. Available from: https://www. easymedicaldevice.com/mdr-transition [Last accessed on 2022 Nov 17].

Nicolas MDD vs MDR. Kobridge. Kobridge Colo. Ltd.; 2022. Available from: https://www.kobridgeconsulting.com/mdd-vs-mdr [Last accessed on 2022 Nov 17].

Europe CE Marking Regulatory Process for Medical Devices; 2013. Available from: https://www.emergobyul.com/resources/europe-process-chart [Last accessed on 2022 Nov 17].

Balamuralidhara V, Kumar TP, Ravi V, Radhadevi N. Regulatory guidelines for medical devices in India: An overview. Asian J Pharm 2012;6:10. doi: 10.4103/0973-8398.100125

Brolin S. Global Regulatory Requirements for Medical Devices. Available from: https://www.diva-portal.org/smash/get/diva2:121327/ fulltext01.pdf

Available from: https://www.researchgate.net/publication/324839049_ regulatory_aspects_of_medical_devices_in_India: text=Sanjana%20 P%2C%20Ki,guidelines%20fo

India Approval Process for Medical Devices & IVDs; 2013. Available from: https://www.emergobyul.com/resources/india-process-chart [Last accessed on 2022 Nov 17].

CFDA. Criteria for Medical Device Classification; 2015. Available from: https://www.sfda.gov.cn/WS01/CL0053/124222.html

Marketing Authorization of Medical Devices in China. Available from: https://www.researchgate.net/publication/300052774_Marketing_ authorization_of_medical_devices_in_China [Last accessed on 2022 Aug 08].

CFDA. Provisions for Medical Device Registration (CFDA Order No. 4); 2017. Available from: https://www.sfda.gov.cn/WS01/ CL0053/103756.html [Last accessed on 2017 Oct 13].

Liu W, Shi X, Lu Z, Wang L, Zhang K, Zhang X. Review and approval of medical devices in China: Changes and reform. J Biomed Mater Res B Appl Biomater 2017;106:2093-100.

China NMPA Regulatory Approval Process for Medical Devices; 2016. Available from: https://www.emergobyul.com/resources/china-process-chart [Last accessed on 2022 Nov 17].

Andalam S, Roop P, Malik A, Trew M. Rethinking the Validation Process for Medical Devices: A Cardiac Pacemaker case Study. In: 21st International Symposium on Real-Time Distributed Computing (ISORC). IEEE Publications. New Jersey: IEEE Publications; 2018. doi: 10.1109/ISORC.2018.00027

Fisher J, Henzinger TA. Executable cell biology. Nat Biotechnol 2007;25:1239-49. doi: 10.1038/nbt1356, PMID 17989686

Chen T, Diciolla M, Kwiatkowska M, Mereacre A. Quantitative verification of implantable cardiac pacemakers over hybrid heart models. Inf Comput 2014;236:87-101. doi: 10.1016/j.ic.2014.01.014

Jiang Z, Pajic M, Moarref S, Alur R, Mangharam R. Closed-loop verification of medical devices with model abstraction and refinement. Int J Softw Tool Technol Transf 2013.

Abbas H, Jiang KJ, Jiang Z, Mangharam R. Towards model checking of implantable cardioverter defibrillators. In: Proceedings of the International Conference on Hybrid Systems: Computation and Control; 2016. p. 87-92. doi: 10.1145/2883817.2883841

Ye P, Entcheva E, Smolka SA, Grosu R. Modelling excitable cells using cycle-linear hybrid automata. IET Syst Biol 2008;2:24-32. doi: 10.1049/iet-syb:20070001, PMID 18248083

Yip E, Andalam S, Roop PS, Malik A, Trew M, Ai W, et al. Towards the emulation of the cardiac conduction system for pacemaker testing. Clin Orthop Relat Res 2016.

Andalam S, Ramanna H, Malik A, Roop P, Patel N, Trew ML. Hybrid automata models of cardiac ventricular electrophysiology for real-time computational applications. Annu Int Conf IEEE Eng Med Biol Soc 2016;2016:5595-8. doi: 10.1109/EMBC.2016.7591995, PMID 28269523

Dahms DF. Implantable Pacemaker Testing Guidance. Vol. UCS081382. United States: Food and Drug Administration; 1997.

Smaill BH, Zhao J, Trew ML. Three-dimensional impulse propagation in myocardium: Arrhythmogenic mechanisms at the tissue level. Circ Res 2013;112:834-48. doi: 10.1161/CIRCRESAHA.111.300157, PMID 23449546

Trayanova NA. Your personal virtual heart. IEEE Spectr 2014;51:34- 59. doi: 10.1109/MSPEC.2014.6934929

Wilhelm R, Engblom J, Ermedahl A, Holsti N, Thesing S, Whalley D, et al. The worst-case execution-time problem-overview of methods and survey of tools. ACM Trans Embed Comput Syst 2008;7:1-53. doi: 10.1145/1347375.1347389



How to Cite

S, N. S., V. R. K, and P. NL. “A COMPARATIVE STUDY OF MEDICAL DEVICES AND THEIR REGULATIONS IN US, EU, INDIA, AND CHINA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 3, Mar. 2023, pp. 6-14, doi:10.22159/ajpcr.2023.v16i3.46624.



Review Article(s)